A detailed history of Parnassus Investments, LLC transactions in Natera, Inc. stock. As of the latest transaction made, Parnassus Investments, LLC holds 9,241 shares of NTRA stock, worth $1.62 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,241
Previous 8,589 7.59%
Holding current value
$1.62 Million
Previous $930,000 26.24%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$97.75 - $129.67 $63,733 - $84,544
652 Added 7.59%
9,241 $1.17 Million
Q2 2024

Aug 06, 2024

BUY
$85.28 - $112.6 $129,028 - $170,363
1,513 Added 21.38%
8,589 $930,000
Q1 2024

May 09, 2024

BUY
$59.21 - $92.9 $418,969 - $657,360
7,076 New
7,076 $647,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $17B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Parnassus Investments, LLC Portfolio

Follow Parnassus Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parnassus Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parnassus Investments, LLC with notifications on news.